Clinical Trials for Hrain Biotechnology

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hrain Biotechnology

Clinical Trials (6)

NCT06045091
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
EARLY_PHASE1Recruiting
18 participants
Started: Jul 4, 2023 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT05651178
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
EARLY_PHASE1Recruiting
10 participants
Started: Aug 12, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05594797
Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM
PHASE2Recruiting
100 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2027
1 condition3 sponsors2 locations
NCT05302648
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM
EARLY_PHASE1Active, not recruiting
18 participants
Started: Feb 9, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06760260
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
EARLY_PHASE1Recruiting
7 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05436223
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
PHASE2Recruiting
100 participants
Started: Aug 9, 2021 · Completed: Aug 9, 2026
1 condition2 sponsors1 location